Is new hope on the horizon for obesity?
Bray
George A
GA
Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA. Electronic address: george.Bray@PBRC.edu.
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000627:therapeutic use*; D031204:Caloric Restriction; D005277:Fenfluramine / Q000627:therapeutic use; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat; D016032:Randomized Controlled Trials as Topic; D015431:Weight Loss / Q000187:drug effects*
D019440:Anti-Obesity Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D007783:Lactones; D005277:Fenfluramine; D000077403:Orlistat; C518479:Tesofensine